Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer

T. Klikovits, A. End (Austria)

Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Session: Diagnostic and therapeutic problems in surgical oncology
Session type: E-Communication Session
Number: 453
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Klikovits, A. End (Austria). Comparison of the new and current TNM staging system in bronchoplastic resection for non-small cell lung cancer. Eur Respir J 2010; 36: Suppl. 54, 453

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of clinic and pathological staging in non-small cell lung cancer
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


Surgical multimodality treatment for stage III non-small cell lung cancer (NSCLC)
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Staging and restaging in the era of multimodality treatment
Source: Annual Congress 2006 - Integrative approaches for stage III non-small cell lung cancer
Year: 2006


Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
Source: Breathe, 14 (4) 342; 10.1183/20734735.027118
Year: 2018



Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009

Current surgical treatment of nonsmall cell lung cancer 2001
Source: Eur Respir J 2002; 19: 61S-70S
Year: 2002



Comparative evaluation of resectability, postoperative morbidity and mediastinal downstaging after cisplatin-based chemoinduction versus radiochemoinduction for stage III non-small cell lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 214s
Year: 2003

Contribution of tumor markers to pretreatment staging of operable lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003

Iterative surgical resections in non-small cell lung carcinoma
Source: Virtual Congress 2021 – Oncology, the mediastinum and infectious lung disease
Year: 2021

Imaging for staging stage III nonsmall cell lung cancer
Source: ISSN=ISSN 1810-6838, ISBN=, page=47
Year: 2007

Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

Extra-mediastinal FDG-PET hot-spots in a study of mediastinal staging of non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 458s
Year: 2004

An algorithm for lung cancer staging
Source: School Course 2014- Endoscopic ultrasound in the diagnosing and staging of lung cancer
Year: 2014


Impact of neoadjuvant therapy on tumor resectability and survival of patients with locally advanced non-small cell lung cancer
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011


Long-term survival after surgical resection for non-small cell lung cancer
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015


Survival impact of surgery in the treatment of stage IIIB-IVA non-small cell lung cancer
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018


Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007

Radiotherapy with curative intent for stage I and II non-small cell lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009